ctdna and late recurrence in high-risk, hr , her2- breast cancer
Published 2 years ago • 2.1K plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
2:13
n9831 trial: genes associated with early and late recurrence in her2 breast cancer
-
1:31
mirador: monitoring mrd using ctdna in hr /her2- early breast cancer
-
1:36
ctdna assay for detection of recurrent disease in patients with early-stage breast cancer
-
4:10
bioltalee: ctdna dynamics in hr /her2- advanced breast cancer
-
1:40
the late recurrence of er breast cancer
-
3:01
assessing elacestrant in ctdna-positive patients with er breast cancer
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
2:15
treat ctdna: early elacestrant intervention for er /her2- breast cancer
-
7:02
breast cancer recurrence risk based on ctdna
-
10:17
circulating tumour cells may predict late recurrence in hr-positive breast cancer patients
-
1:26
potential role of ctdna for early-stage breast cancer
-
0:58
real-world monitoring of circulating tumor dna to predict cancer recurrence
-
2:06
elaine 1: esr1 mutations in ctdna from er /her2- mbc treated with lasofoxifene or fulvestrant
-
16:11
ctdna in breast cancer | 2023 coeds discussion series fort lauderdale
-
0:45
the evolution of her2-low breast cancer from primary to recurrence
-
1:46
success-a trial: ctdna screening's potential in early-stage breast cancer recurrence prediction
-
2:14
survival in premenopausal hr /her2- breast cancer with micro-metastasis and 21-gene score
-
0:53
prognostic trials for 21-gene oncotypedx in hr /her2- breast cancer with micrometastases
-
2:51
personalized ctdna during neoadjuvant therapy in pts with early-stage breast cancer